Type:
Whole Allergen
Whole Allergen
Whole Allergen
Amoxicilloyl
c6
Oral, parenteral
Amoxicillin
XM7CM1
(ICD-11 is currently under implementation by WHO and the ICD-11 codes displayed in the encyclopedia may not yet be available in all countries)
Amoxicillin is a semi-synthetic, broad-spectrum, penicillinase-sensitive aminopenicillin with a beta-lactam ring and side chain as sites for immunological recognition. Amoxicilloyl is the major allergenic determinant of amoxicillin, produced when its β-lactam ring opens and covalently attaches to proteins, forming a stable hapten-protein conjugate. Most common manifestations of allergy to the penicillin family are benign immediate and delayed cutaneous reactions, however, penicillin allergy is also the leading cause of fatal drug anaphylaxis. Clinical history alone is not reliable for the diagnosis of penicillin allergy, hence one or more among skin and blood tests for penicillin sensitization and penicillin provocation tests are required. Penicillin skin testing and penicillin-specific IgE determination are highly specific but lack diagnostic sensitivity for immediate allergic reactions. A clearly positive IgE test to penicillin has been proposed by international guidelines as a criterion for sparing drug provocation tests for penicillin allergy diagnosis.
Despite a reported global prevalence of 6%-25% for penicillin allergy, fewer than 10% of suspected cases are truly allergic to penicillin. The burden of penicillin allergy overdiagnosis has personal and public health implications. Factors predictive of genuine allergy to penicillins include frequent antibiotic use, female gender, older age, a family history of allergies, and atopic conditions. Cross-reactivity between aminopenicillins and benzylpenicillins and between aminopenicillins and other beta-lactams, such as cephalosporins, is variable, depending on the similarity in chemical structures.
Nature
Penicillins are a family of natural and semi-synthetic antibiotics composed of a beta-lactam ring fused with a thiazolidine ring, collectively denoted as a penam ring, and an acyl side chain (Wright 1999). Aminopenicillins including amoxicillin and ampicillin are semisynthetic penicillins obtained from the parent drug of the penicillin family, the natural antibiotic penicillin G (benzylpenicillin) synthesized by Penicillium notatum (Lobanovska et al. 2017). Amoxicillin is a broad-spectrum, penicillinase-sensitive beta-lactam aminopenicillin that contains a side chain 2-amino-2-(4-hydroxyphenyl) acetamido group at position 6 of the penam ring (Tang et al. 2019, Torres et al. 2016).
Amoxicillin is available as an injectable formulation (amoxicillin sodium salt), which is water-soluble, and as oral formulations (amoxicillin trihydrate) (Torres et al. 2016).
Like other small molecules, penicillins are not immunogenic by themselves, instead requiring binding to a carrier protein, such as serum albumin, through a process called haptenization.
Several mechanisms, namely IgE (immediate reactions) and T cells (nonimmediate reactions), can trigger allergic reactions to amoxicillin. IgE to amoxicillin can target the side chain, the thiazolidine ring, or to the conjugate formed by the beta-lactam ring and the carrier protein (Torres et al. 2016). While side chain-specific structures are important for immunological recognition, the entire molecule is needed to cause an allergic reaction (Blanca-Lopez et al. 2015).
Clinical reactivity to amoxicillin may be selective if IgE is directed to the side chain, or cross-reactive with other penicillins if IgE is directed to the beta-lactam ring (Torres et al. 2016). The reactivity profiles are stable over time in a majority of patients (Blanca-Lopez et al. 2015).
Worldwide distribution
Penicillin allergy, with an estimated prevalence of 6%-25%, is the most reported drug allergy globally. In keeping with other penicillins, the estimated incidence of allergy to amoxicillin was found to range between 1% and 10 % (Romano et al. 2014, Weisser et al. 2016). It is estimated that allergological work-up could delabel beta-lactam allergy in 90% of patients (Brockow et al. 2025).
Indeed, <10% of people labeled as penicillin allergic have a true immunoglobulin (Ig)E-mediated hypersensitivity to penicillin, while most of these could safely tolerate penicillin (Kouma et al. 2023, Meng et al. 2016). This is possibly due to two reasons: inaccurate diagnosis and the gradual loss of sensitization with time (Siew et al. 2019).
In a prospective Spanish study conducted in 510 pediatric patients (< 16 years) with a clinical history of reactions to beta-lactam drugs, amoxicillin involvement was suspected in 349 cases (68.5%) based on the clinical history, but confirmed in only 39 cases (11%). Overall, allergological workup confirmed genuine beta-lactam allergy in only 54 cases (10.6%) from this cohort (Torres-Rojas et al. 2021).
Among 221 patients labeled as having amoxicillin hypersensitivity, only 37 (16.7%) had confirmed amoxicillin allergy after SPT and drug provocation test (DPT) in a UK-based retrospective study from 2013-2019. Among 100 patients exposed to amoxicillin-clavulanic acid as index drug, amoxicillin allergy was confirmed in 47 (Wang et al. 2022).
A retrospective study conducted on drug-induced anaphylaxis reports (January 2004 – December 2014) from the Beijing Pharmacovigilance Database retrieved 1189 cases (mean age 47.6 years) with 39.3% (467/1189) attributed to antibiotics. Among the antibiotics, beta-lactams were suspected in most cases (58.9%; 275/467), and among these, amoxicillin was suspected in 8 cases, either alone or in combination with clavulanic acid (Zhao et al. 2018).
In a Thailand-based cross-sectional study on 13,959 patients who had received at least one treatment course with penicillins and/or cephalosporins, adverse drug reactions were documented in 99 patients of whom 29 (29.3%) had received amoxicillin and 19 (19.2%) had received the amoxicillin – clavulanic acid combination (Aiyaka et al. 2018).
A surveillance-based study was conducted on 6542 children in US emergency departments between 2011-2015 to evaluate antibiotic adverse drug events (ADEs) leading to emergency visits. ADEs comprised allergic reactions, but also other adverse effects, effects of excess dose, and others. Amoxicillin was found to be the leading cause of ADE in children ≤9 years; however, ADE proportion decreased with age (≤2 years [67.6%], 3-4 years [54.5%], and 5-9 years [44.7%]) (Lovegrove et al. 2019).
Using 2013 - 2023 data in the FDA Adverse Event Reporting System, adverse reactions to penicillins were reported as anaphylaxis more often than other medications (6.5% compared to 0.23%). Among 3176 penicillin-related anaphylaxis reports, 2373 (74.7%) concerned amoxicillin, either alone (1353 cases) or in combination with clavulanic acid (1,020 cases). Thus, anaphylaxis to amoxicillin-containing drugs had a reporting odd risk of 1.97 (95%CI 1.82-2.14) compared with all other penicillins (Belmont et al. 2025).
Risk factors
Risk and predictive factors contribute to the stratification of patients’ risk of having genuine beta-lactam allergy, and thus to the choice of the diagnostic strategy (Brockow et al. 2025).
A study identified antibiotic overuse to be significantly associated with the risk of allergic diseases in both adults and children (Chen et al. 2019). Penicillin allergy has also been found to be more prevalent in females and older individuals (Yuson et al. 2022). The presence of atopic diseases like asthma, family history of drug-induced allergy, and higher age at reactions may be considered risk factors for true amoxicillin allergy in children (Faitelson et al. 2018). Severe systemic reactions (anaphylaxis) are consistently more frequently reported in association with parenteral administration than with oral intake of penicillins ((Belmont et al. 2025, Liang et al. 2020).
Pediatric issues
Beta-lactam antibiotics are the most prevalent medications that trigger allergic reactions in children. Approximately 5% of the pediatric population globally is diagnosed with a penicillin allergy but upon careful diagnostic testing, <5% of these cases are confirmed (Kwok et al. 2023). Conversely, delayed rashes occurring during amoxicillin or ampicillin treatment in children with acute Epstein-Barr primoinfection (infectious mononucleosis) may be due to an allergic mechanism more often than previously suspected, since 5 of 10 children investigated in a case series exhibited T-lymphocyte activation to amoxicillin and ampicillin (Mori et al. 2019).
Among different penicillin antibiotics, amoxicillin is one of the most frequently prescribed antibiotics in children for the treatment of bacterial infections (community-acquired) and allergic and non-allergic reactions to amoxicillin are common in children (Weisser et al. 2016).
The evaluation of 222 pregnant women labeled as penicillin-allergic with clinical history, appropriate skin tests and if necessary a drug challenge test which was performed with amoxicillin resulted in the delabeling of 209 (95%) of these patients, confirming the overestimation of penicillin allergy diagnosis (Wolfson et al. 2021).
Main
Exposure to amoxicillin mainly occurs during amoxicillin treatment via two routes: orally in the form of a solution, suspension, or tablets, and parenterally via injections of amoxicillin sodium salt (Torres et al. 2016). Occupational exposure occurs via direct skin contact and potentially via inhalation in healthcare and pharmaceutical workers.
Penicillin allergies are divided into two categories: immediate and delayed, each stemming from different immune responses. Immediate reactions happen within 1 to 6 hours of taking the drug, with symptom onset taking place during the first 15 minutes in 85% of patients and can range from urticaria to life-threatening anaphylaxis. Delayed reactions occur at least 6 hours after dosing, with a majority taking place 1 to 2 weeks after intake, and may present as benign maculopapular exanthema but severe, life-threatening presentations are also reported, such as DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) syndrome, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (Castells et al. 2019, Khan et al. 2022, Kopač et al. 2012).
In particular, amoxicillin and other aminopenicillins present with a higher risk for benign drug-induced delayed exanthema, typically described during acute Epstein-Barr virus infection (Castells et al. 2019).
A study evaluating hypersensitivity reactions to beta-lactams in children reported that the most prevalent presentations of immediate hypersensitivity to amoxicillin were mild to moderate, ranging from urticaria and exanthema to angioedema and asthma (Torres-Rojas et al. 2021). A similar type of mild immediate reaction of urticaria and angioedema was observed in another study involving adult patients allergic to amoxicillin or penicillin (Gateman et al. 2021).
Risk stratification is vital for healthcare providers in diagnosing and managing penicillin allergies, affecting decisions regarding beta-lactam therapy or alternatives. High-risk patients may show severe immediate reactions such as anaphylaxis, low blood pressure, laryngeal edema, bronchospasm in association with urticaria, angioedema, and generalized exanthema. Conversely, low-risk patients are reported to have milder immediate reactions like isolated pruritus, gastrointestinal symptoms, contact dermatitis, or mild maculopapular exanthema (Romano et al. 2020).
Clinical predictors for true beta-lactam allergies are lacking, hence suspected allergy cases need to be confirmed by specific IgE testing and if necessary, by an in vivo DCT (Siew et al. 2019).
Skin testing for amoxicillin is performed with the water soluble formulation (Khan et al. 2022, Torres et al. 2016). Serum specific IgE testing is safe, is not influenced by ongoing antihistamine medication and can be performed in primary care settings (Lendal et al. 2025). Both skin tests and IgE tests for penicillin allergy display high specificity but insufficient sensitivity, with a systematic review and meta-analysis finding 96.8% and 97.4%, and 30.7% and 19.4%, respectively (Sousa-Pinto et al. 2021). However, a novel chemiluminescence immunoassay (CLIA) with synthetic sIgE was found to exhibit 100% clinical specificity and 73% sensitivity in diagnosing amoxicillin allergic reactions in patients (Quintero-Campos et al. 2023).
Similar to other penicillins, the interpretation of amoxicillin-specific IgE should ideally consider the level of total IgE (Garvey et al. 2019). Low levels of penicillin-specific IgE display lower diagnostic specificity in the context of elevated total IgE levels (Lendal et al. 2025, Vultaggio et al. 2009, Zidarn et al. 2009). Penicillin sensitization decreases over time and may become undetectable with both skin tests and serum specific IgE (Hjortlund et al. 2014, Lendal et al. 2025). The half-life of serum specific IgE was found to be 1 year in most patients, (Hjortlund et al. 2014). Accordingly, penicillin allergy work-up is recommended 4-6 weeks after the drug-induced reaction (Demoly et al 2014) and no later than one year after the index reaction (Hjortlund et al. 2014, Lendal et al. 2025). Early investigation can be performed with specific IgE determination in acute samples obtained at the time of an immediate reaction (Garvey et al. 2019). Specific IgE testing is recommended as the first-line investigation in high-risk patients, e.g. having experienced severe immediate reactions to penicillin (Demoly et al. 2014, Dona et al. 2025). A clearly positive IgE test can be considered sufficient for the diagnosis of beta-lactam allergy in patients with an evocative clinical history, especially anaphylaxis (Garvey et al. 2019, Romano et al. 2020)
If specific IgE tests are negative, additional examinations with skin and drug provocation test become necessary (Dona et al. 2025, Lendal et al. 2025).
Conversely, USA practice parameter recommends skin testing over blood IgE testing due to lower diagnostic sensitivity of the latter (Khan et al. 2022).
Prevention strategies
Avoidance
It is considered that patients with confirmed amoxicillin allergy must not be administered the trigger and cross-reactive molecules, based on similar side chains, particularly those belonging to the same subclass, such as other aminopenicillins and aminocephalosporins: ampicillin, cefaclor, cephalexine (Brockow et al. 2025). However, the rate of real-world cross-reactivity might be lower than inferred from chemical structures (Liang et al. 2020, Macy et al. 2022, Ramsey 2022). In addition, a majority of selective reactors to amoxicillin with IgE targeting the side chain tolerate other penicillins (Torres et al. 2016). The allergological work-up of patients reporting reactions to a combination of amoxicillin and clavulanic acid may result in the latter being the trigger, and amoxicillin can be safely administered (Blanca-Lopez et al. 2015, Torres et al. 2016).
Cross-reactivity
Partial cross-reactivity within the penicillin family is reported, due to shared structural features such as side chains and the beta-lactam ring (Bhattacharya 2010, Brockow et al. 2025). Aminopenicillins (such as amoxicillin and ampicillin) have a side chain identical or similar to that of several first and second generation cephalosporins, explaining their cross-reactivity (Brockow et al. 2025, Romano et al. 2020, Trubiano et al. 2017). However, cefazolin and cefuroxime do not exhibit structure similarity with amoxicillin (Romano et al. 2020). Cross reactivity has also been found between aminopenicillins and benzylpenicillin (Caruso et al. 2021). In a study conducted in the UK (2013-2019), 15/36 (42%) of patients with confirmed amoxicillin hypersensitivity were found to cross-react with other penicillins, especially with benzylpenicillin (87%) (Wang et al. 2022).
Allergen information
Amoxicillin is a commonly prescribed semi-synthetic, broad-spectrum, penicillinase-sensitive BL antibiotic of the aminopenicillin group. Its allergenic properties require haptenization with carrier proteins such as serum albumin. IgE to amoxicillin can target the side chain, the thiazolidine ring, or to the conjugate formed by the beta-lactam ring and the carrier protein.
Clinical information
Amoxicillin hypersensitivity reactions with a demonstrated adaptive immune mechanism are termed amoxicillin allergy. Immediate amoxicillin allergy (1-6 hours after administration) is mostly IgE-dependent, while delayed amoxicillin allergy (>6hours after administration) is mostly T cell-dependent. Urticaria and exanthema are the most common symptoms. Similar to other penicillins, confirmed amoxicillin allergy represents around 10% of patients with a label of amoxicillin allergy, prompting recommendations for proactive amoxicillin allergy delabeling after risk stratification.
Cross-reactivity
Clinical reactivity to amoxicillin may be selective if IgE is directed to the side chain, or cross-reactive with other penicillins if IgE is directed to the beta-lactam ring. The side chain of amoxicillin is identical or similar to that of several first- and second-generation cephalosporins, resulting in partial cross-reactivity with potential clinical relevance.
Compiled by Turacoz.
Reviewed by Dr. Joana Vitte, September 2025
Aiyaka, P. and W. Techakehakij (2018). "The prevalence of cross-reactivity of cephalosporin in penicillin-allergic patients: A cross-sectional study in Thailand." Hong Kong Journal of Emergency Medicine 26(3): 151-155.
Belmont AP, Novotny S, Mukherjee EM, Park D, Wong KH, Martin-Pozo MD, Phillips EJ, Stone CA Jr. Anaphylaxis to Penicillin: "Harvesting Insights from the Food and Drug Administration's Adverse Event Reporting System." (2025). J Allergy Clin Immunol Pract. 31:S2213-2198(25)00729-9.
Blanca-Lopez, N., D. Perez-Alzate, F. Ruano, M. Garcimartin, V. de la Torre, C. Mayorga, M. L. Somoza, J. Perkins, M. Blanca, M. G. Canto and M. J. Torres (2015). "Selective immediate responders to amoxicillin and clavulanic acid tolerate penicillin derivative administration after confirming the diagnosis." Allergy 70(8): 1013-1019.
Brockow, K., W. Pfutzner, B. Wedi, G. Wurpts, A. Trautmann, B. Kreft, T. Buhl, M. Sulk, A. Recke, K. Scherer, S. Wohrl, I. Neustadter, R. Treudler, C. Querbach and M. Worm (2025). "Recommendations on how to proceed in case of suspected allergy to penicillin/beta-lactam antibiotics: Position paper of the German Society for Allergology and Clinical Immunology (DGAKI) in cooperation with the German Society for Pediatric Allergology (GPA), Austrian Society for Allergology and Immunology (OGAI) and the Swiss Society for Allergology and Immunology (SGAI)." Allergol Select 9: 28-39.
Caruso, C., R. L. Valluzzi, S. Colantuono, F. Gaeta and A. Romano (2021). "beta-Lactam Allergy and Cross-Reactivity: A Clinician's Guide to Selecting an Alternative Antibiotic." J Asthma Allergy 14: 31-46.
Castells, M., D. A. Khan and E. J. Phillips (2019). "Penicillin Allergy." N Engl J Med 381(24): 2338-2351.
Chen, Y. L., W. J. Sng, Y. Wang and X. Y. Wang (2019). "Antibiotic overuse and allergy-related diseases: an epidemiological cross-sectional study in the grasslands of Northern China." Ther Clin Risk Manag 15: 783-789.
Demoly, P., N. F. Adkinson, K. Brockow, M. Castells, A. M. Chiriac, P. A. Greenberger, D. A. Khan, D. M. Lang, H. S. Park, W. Pichler, M. Sanchez-Borges, T. Shiohara and B. Y. Thong (2014). "International Consensus on drug allergy." Allergy 69(4): 420-437.
Dona, I., M. Salas, E. Moreno, M. Ferrer, C. Mayorga and M. J. Torres (2025). "An algorithm for the diagnosis of beta-lactam allergy, 2024 update." Allergy 80(2): 633-637.
Faitelson, Y., M. Boaz and I. Dalal (2018). "Asthma, Family History of Drug Allergy, and Age Predict Amoxicillin Allergy in Children." J Allergy Clin Immunol Pract 6(4): 1363-1367.
Garvey, L. H., D. G. Ebo, P. M. Mertes, P. Dewachter, T. Garcez, P. Kopac, J. J. Laguna, A. M. Chiriac, I. Terreehorst, S. Voltolini and K. Scherer (2019). "An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions." Allergy 74(10): 1872-1884.
Gateman, D. P., J. E. Rumble, J. L. P. Protudjer and H. Kim (2021). "Amoxicillin oral provocation challenge in a primary care clinic: a descriptive analysis." CMAJ Open 9(2): E394-E399.
Hjortlund, J., C. G. Mortz, T. B. Stage, P. S. Skov, R. Dahl and C. Bindslev-Jensen (2014). "Positive serum specific IgE has a short half-life in patients with penicillin allergy and reversal does not always indicate tolerance." Clin Transl Allergy 4: 34.
Khan, D. A., A. Banerji, K. G. Blumenthal, E. J. Phillips, R. Solensky, A. A. White, J. A. Bernstein, D. K. Chu, A. K. Ellis, D. B. K. Golden, M. J. Greenhawt, C. C. Horner, D. Ledford, J. A. Lieberman, J. Oppenheimer, M. A. Rank, M. S. Shaker, D. R. Stukus, D. Wallace, J. Wang, E. Chief, D. A. Khan, D. B. K. Golden, M. Shaker, D. R. Stukus, C. Workgroup, D. A. Khan, A. Banerji, K. G. Blumenthal, E. J. Phillips, R. Solensky, A. A. White, R. Joint Task Force on Practice Parameters, J. A. Bernstein, D. K. Chu, A. K. Ellis, D. B. K. Golden, M. J. Greenhawt, C. C. Horner, D. Ledford, J. A. Lieberman, J. Oppenheimer, M. A. Rank, M. S. Shaker, D. R. Stukus, D. Wallace and J. Wang (2022). "Drug allergy: A 2022 practice parameter update." J Allergy Clin Immunol 150(6): 1333-1393.
Kopač , Mihaela Z and Mitja K (2012). "Epidemiology of hypersensitivity reactions to penicillin in Slovenia." Acta Dermatovenerologica 21: 65-67.
Kouma, M. A., J. M. Guastadisegni, L. Yang, D. N. Maxwell, D. F. Storey and R. J. Arasaratnam (2023). "Challenges and opportunities related to penicillin allergy in the Veterans Health Administration: a narrative review." Antimicrob Steward Healthc Epidemiol 3(1): e174.
Kwok, M., K. L. Heard, A. May, R. Pilgrim, J. Sandoe, S. Tansley and J. Scott (2023). "Health outcomes of penicillin allergy testing in children: a systematic review." J Antimicrob Chemother 78(4): 913-922.
Lendal, V., S. Fransson, H. Mosbech, J. B. Boel, N. Kahlhofen, L. H. Blom, L. K. Poulsen and L. H. Garvey (2025). "Clinical Relevance of Specific IgE in Penicillin Allergy Investigation." Int Arch Allergy Immunol:186(4):303-310.
Liang, E. H., L. H. Chen and E. Macy (2020). "Adverse Reactions Associated with Penicillins, Carbapenems, Monobactams, and Clindamycin: A Retrospective Population-based Study." J Allergy Clin Immunol Pract 8(4): 1302-1313 e1302.
Lobanovska, M. and a. G. Pilla (2017). "Penicillin’s Discovery and Antibiotic Resistance: Lessons for the Future?" Yale Journal of Biology and Medicine 90: 135-145.
Lovegrove, M. C., A. I. Geller, K. E. Fleming-Dutra, N. Shehab, M. R. P. Sapiano and D. S. Budnitz (2019). "US Emergency Department Visits for Adverse Drug Events From Antibiotics in Children, 2011-2015." J Pediatric Infect Dis Soc 8(5): 384-391.
Macy, E., W. W. Crawford, M. T. Nguyen, J. L. Adams, E. A. McGlynn and T. A. McCormick (2022). "Population-Based Incidence of New Ampicillin, Cephalexin, Cefaclor, and Sulfonamide Antibiotic "Allergies" in Exposed Individuals with and without Preexisting Ampicillin, Cephalexin, or Cefaclor "Allergies"." J Allergy Clin Immunol Pract 10(2): 550-555.
Meng, J., D. Thursfield and J. J. Lukawska (2016). "Allergy test outcomes in patients self-reported as having penicillin allergy: Two-year experience." Ann Allergy Asthma Immunol 117(3): 273-279.
Mori, F., L. Fili, S. Barni, M. Giovannini, M. Capone, E. M. Novembre and P. Parronchi (2019). "Sensitization to amoxicillin/clavulanic acid may underlie severe rashes in children treated for infectious mononucleosis." J Allergy Clin Immunol Pract 7(2): 728-731 e721.
Quintero-Campos, P., R. Gozalbo-Rovira, J. Rodriguez-Diaz, A. Maquieira and S. Morais (2023). "Standardizing In Vitro beta-Lactam Antibiotic Allergy Testing with Synthetic IgE." Anal Chem 95(32): 12113-12121.
Ramsey, A. (2022). "Cephalexin, Cefaclor, and Ampicillin: Points in the Picture of beta-Lactam Cross-Reactivity." J Allergy Clin Immunol Pract 10(2): 556-557.
Romano, A., M. Atanaskovic-Markovic, A. Barbaud, A. J. Bircher, K. Brockow, J. C. Caubet, G. Celik, J. Cernadas, A. M. Chiriac, P. Demoly, L. H. Garvey, C. Mayorga, A. Nakonechna, P. Whitaker and M. J. Torres (2020). "Towards a more precise diagnosis of hypersensitivity to beta-lactams - an EAACI position paper." Allergy 75(6): 1300-1315.
Romano, A. and R. Warrington (2014). "Antibiotic allergy." Immunol Allergy Clin North Am 34(3): 489-506, vii.
Siew, L. Q. C., P. H. Li, T. J. Watts, I. Thomas, K. L. Ue, M. R. Caballero, K. Rutkowski, S. J. Till, P. Pillai and R. Haque (2019). "Identifying Low-Risk Beta-Lactam Allergy Patients in a UK Tertiary Centre." J Allergy Clin Immunol Pract 7(7): 2173-2181 e2171.
Sousa-Pinto, B., I. Tarrio, K. G. Blumenthal, L. Araujo, L. F. Azevedo, L. Delgado and J. A. Fonseca (2021). "Accuracy of penicillin allergy diagnostic tests: A systematic review and meta-analysis." J Allergy Clin Immunol 147(1): 296-308.
Tang, B., Y. Wu, C. Kou, Y. Qi, H. Qi, H. Xu, S. Leroux, X. Huang, Y. Zhou, Y. Zheng and E. Jacqz-Aigrain (2019). "Population pharmacokinetics and dosing optimization of amoxicillin in neonates and young infants." Antimicrobial Agents and Chemotherapy 63(2): 10-128.
Torres-Rojas, I., D. Perez-Alzate, M. L. Somoza, E. Haroun Diaz, F. J. Ruano Perez, A. Prieto-Moreno Pfeifer, T. W. Jimenez-Rodriguez, J. Fernandez Sanchez, M. Blanca, G. Canto Diez and N. Blanca-Lopez (2021). "Patterns of response and drugs involved in hypersensitivity reactions to beta-lactams in children." Pediatr Allergy Immunol 32(8): 1788-1795.
Torres, M. J., M. I. Montanez, A. Ariza, M. Salas, T. D. Fernandez, N. Barbero, C. Mayorga and M. Blanca (2016). "The role of IgE recognition in allergic reactions to amoxicillin and clavulanic acid." Clin Exp Allergy 46(2): 264-274.
Trubiano, J. A., C. A. Stone, M. L. Grayson, K. Urbancic, M. A. Slavin, K. A. Thursky and E. J. Phillips (2017). "The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration." J Allergy Clin Immunol Pract 5(6): 1532-1542.
Vultaggio, A., A. Matucci, G. Virgili, O. Rossi, L. Fili, P. Parronchi, S. Romagnani and E. Maggi (2009). "Influence of total serum IgE levels on the in vitro detection of beta-lactams-specific IgE antibodies." Clin Exp Allergy 39(6): 838-844.
Wang, X. M., L. Kennard, K. Rutkowski, M. E. F. Bruco, R. Mirakian and A. Wagner (2022). "Amoxicillin hypersensitivity: Patient outcomes in a seven-year retrospective study." Ann Allergy Asthma Immunol 129(4): 507-514 e502.
Weisser, C. and M. Ben-Shoshan (2016). "Immediate and non-immediate allergic reactions to amoxicillin present a diagnostic dilemma: a case series." J Med Case Rep 10: 10.
Wolfson, A. R., C. M. Mancini, A. Banerji, X. Fu, A. S. Bryant, N. A. Phadke, E. S. Shenoy, W. Arman, Y. Zhang and K. G. Blumenthal (2021). "Penicillin Allergy Assessment in Pregnancy: Safety and Impact on Antibiotic Use." J Allergy Clin Immunol Pract 9(3): 1338-1346.
Yuson, C., S. Shakib and W. Smith (2022). "Prevalence of drug allergy in South Australia." Intern Med J 52(11): 1957-1961.
Zhao, Y., S. Sun, X. Li, X. Ma, H. Tang, L. Sun, S. Zhai and T. Wang (2018). "Drug-induced anaphylaxis in China: a 10 year retrospective analysis of the Beijing Pharmacovigilance Database." Int J Clin Pharm 40(5): 1349-1358.
Zidarn, M., M. Silar, M. Vegnuti, P. Korosec and M. Kosnik (2009). "The specificity of tests for anti-beta-lactam IgE antibodies declines progressively with increase of total serum IgE." Wien Klin Wochenschr 121(9-10): 353-356.